Options Brief: Orexigen Therapeutics

Shares of Orexigen Therapeutics OREX are higher on the session by 4.27%, trading at $1.71. Overall put volume is now running at 3.15x the daily average, with 68% of all puts traded being purchases on the offer. 1,147 contracts have traded on the session so far. Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity.